Safety and Efficacy of Intravenous Hydromorphone as an Analgesic Alternative to Morphine in Acute Pain: A Randomized Clinical Trial

2006 ◽  
Vol 13 (5Supplement 1) ◽  
pp. S156-S156
Author(s):  
A. K. Chang
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Acute Pain ◽  
Safety And Efficacy

Safety and Efficacy of Hydromorphone as an Analgesic Alternative to Morphine in Acute Pain: A Randomized Clinical Trial

2006 ◽  
Vol 48 (2) ◽  
pp. 164-172 ◽  
Author(s):  
Andrew K. Chang ◽  
Polly E. Bijur ◽  
Robert H. Meyer ◽  
Mark K. Kenny ◽  
Clemencia Solorzano ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Acute Pain ◽  
Safety And Efficacy

Safety and efficacy of hydromorphone as an analgesic alternative to morphine in acute pain: A randomized clinical trial

Acute Pain ◽  
2006 ◽  
Vol 8 (4) ◽  
pp. 191
Author(s):  
A.K. Chang ◽  
P.E. Bijur ◽  
R.H. Meyer ◽  
M.K. Kenny ◽  
C. Solorzano ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Acute Pain ◽  
Safety And Efficacy

scholarly journals Using Stories to Communicate Individual Risk for Opioid Prescriptions: Study Protocol for the Life STORRIED Multicenter Randomized Clinical Trial

2018 ◽  
Author(s):  
Zachary F Meisel ◽  
Esha Bansal ◽  
Marilyn M Schapira ◽  
Jeanmarie Perrone ◽  
Carolyn C Cannuscio ◽  
...  
Keyword(s):  
United States ◽  
Clinical Trial ◽  
Risk Communication ◽  
Randomized Clinical Trial ◽  
Acute Care ◽  
Acute Pain ◽  
The United States ◽  
Risk Information ◽  
Information Sheet ◽  
Health Crisis

Abstract Background: Prescription opioid abuse in the United States is a devastating public health crisis, of which many chronic opioid users were originally prescribed the medication for acute pain. Narrative enhanced risk communication may improve patient outcomes such as knowledge of opioid risk and opioid use behaviors in the setting of acute pain. Methods & Design: Patients presenting to the acute care facilities of four geographically and ethnically diverse United States hospital centers with renal colic or musculoskeletal back pain will be eligible for this multicenter randomized clinical trial. A control group of patients receiving a standardized, general risk information sheet will be compared to two intervention groups, one receiving the risk information sheet plus a probabilistic opioid risk tool and another receiving the risk information sheet plus a narrative enhanced probabilistic opioid risk tool. We will study the effect of probabilistic and narrative enhanced opioid risk communication on: 1) knowledge as measured by risk awareness and treatment preferences for fewer opioids; 2) reduced use of opioids as measured by quantity of opioids taken, functional improvement, and repeat use of unscheduled visits for pain; 3) patient-provider alignment as measured by concordance between patient preference and finalized prescription plan and the presence of shared decision making. To assess these outcomes, we will administer baseline patient surveys during acute care admission and follow-up surveys at predetermined times during the ninety days after discharge. Discussion: This study seeks to assess the potential clinical role of narrative enhanced, risk-informed communication for acute pain management in acute care settings. This paper outlines the protocol used to implement the study and highlights crucial methodological, statistical, stakeholder involvement, and dissemination considerations.

The randomized clinical trial of safety and efficacy of oral tramadol in patients undergoing colonoscopy

2021 ◽  
Vol 10 (2) ◽  
pp. 261
Author(s):  
MohammadHosein Farzaei ◽  
Mehdi Zobeiri ◽  
Teimour Kamari ◽  
Mansour Rezaei
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Safety And Efficacy

scholarly journals Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer

2015 ◽  
Vol 19 (3) ◽  
pp. 927-938 ◽  
Author(s):  
Kohei Shitara ◽  
Kei Muro ◽  
Yasuhiro Shimada ◽  
Shuichi Hironaka ◽  
Naotoshi Sugimoto ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Line Treatment ◽  
Second Line ◽  
Safety And Efficacy ◽  
Subgroup Analyses

scholarly journals Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial

Vaccine ◽  
2016 ◽  
Vol 34 (3) ◽  
pp. 313-319 ◽  
Author(s):  
David I. Bernstein ◽  
Flor M. Munoz ◽  
S. Todd Callahan ◽  
Richard Rupp ◽  
Susan H. Wootton ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Adolescent Girls ◽  
Glycoprotein B ◽  
Safety And Efficacy
Sign in / Sign up

Export Citation Format

Share Document